TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America

Carcinogenesis

Volumn 31, Issue 6, 2009, Pages 1054-1059

  Szymanska K ^a   Levi, J E ^b   Menezes, A ^c   Wunsch Filho V ^b   Eluf Neto, J ^b   Koifman, S ^d   Matos, E ^e   Daudt, A W ^f   Curado, M P ^a,g   Villar, S ^a   Pawlita, M ^h   Waterboer, T ^h   Boffetta, P ^a   Hainaut, P ^a   Brennan, P ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^f HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^g Goiania Cancer Registry   (Brazil)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE; MUTANT PROTEIN; PROTEIN P53; THYMINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; CPG ISLAND; DIGESTIVE SYSTEM CANCER; EXON; FEMALE; GENE INACTIVATION; GENE MUTATION; GENETIC ASSOCIATION; HEAD AND NECK CANCER; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOUTH AMERICA; UPPER AERODIGESTIVE TRACT CANCER; CASE CONTROL STUDY; CLINICAL TRIAL; COCARCINOGENESIS; ESOPHAGUS TUMOR; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; MULTICENTER STUDY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CASE-CONTROL STUDIES; COCARCINOGENESIS; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PILOT PROJECTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS; SOUTH AMERICA;

EID: 77953921202     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp212     Document Type: Article

References (24)

1. Ferlay, J. et al. (2004) GLOBOCAN 2002: Cancer Incidence. Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, version 2.0. IARC Press, Lyon.
2. IARC (1988) IARC monographs on the evaluation of carcinogenic risks to humans. Alcohol drinking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 44. IARC Press, Lyon.
3. IARC (2004) IARC monographs on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 83. IARC Press. Lyon.
4. Castellsague, X. et al. (2000) Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int. J. Cancer, 88, 658-664.
5. Goldenberg, D. et al. (2003) The beverage mate: a risk factor for cancer of the head and neck. Head Neck, 25, 595-601.
6. Dai, M. et al. (2004) Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Res., 64, 468-471.
7. Sankaranarayanan, R. et al. (1998) Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res., 18, 4779-4786.
8. Petitjean, A. et al. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat., 28, 622-629.
9. Chaves, A.C. et al. (2004) Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas. Int. J. Oncol., 24, 295-303.
10. Hollstein, M.C. et al. (1991) Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51, 4102-4106.
11. Nagai, M.A. et al. (1998) TP53 genetic alterations in head-and-neck carcinomas from Brazil. Int. J. Cancer, 76, 13-18.
12. Putz, A. et al. (2002) TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors. Int. J. Cancer, 98, 99-105.
13. Pao, W. et al. (2004) EGF receptor gene mutations are common in lung cancers from "never smokers"' and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc. Natl Acad. Sci. USA, 101, 13306-13311.
14. Lee, J.W. et al. (2005) Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin. Cancer Res., 11, 2879-2882.
15. Loeffler-Ragg, J. et al. (2006) Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma. Eur. J. Cancer, 42, 109-111.
16. Willmore-Payne, C. et al. (2006) Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck. Mod. Pathol., 19, 634-640.
17. Le Calvez, F. et al. (2005) Arrayed primer extension resequencing of mutations in the TP53 tumor suppressor gene: comparison with denaturing HPLC and direct sequencing. Clin. Chem., 51, 1284-1287.
18. Waterboer, T. et al. (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin. Chem., 51, 1845-1853.
19. Clifford, G.M. et al. (2007) Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol. Biomarkers Prev., 16, 1874-1879.
20. Le Calvez, F. et al. (2005) TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res., 65, 5076-5083.
21. Breton, J. et al. (2003) Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France). Mutagenesis, 18, 299-306.
22. Noori, P. et al. (2001) Mutational spectrum induced by acetaldehyde in the HPRT gene of human T lymphocytes resembles that in the p53 gene of esophageal cancers. Carcinogenesis, 22, 1825-1830.
23. van Heerden, W.F. et al. (1998) Correlation between p53 gene mutation, p53 protein labeling and PCNA expression in oral squamous cell carcinomas. Anticancer Res., 18, 237-240.
24. Mounawar, M. et al. (2007) Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history. Cancer Res., 67, 5667-5672.